Skip to content Skip to sidebar Skip to footer



Characterizing the maternal immune environment during pregnancy: Implications for autism spectrum disorders – Now Complimentary on Demand

unnamed (1)

In case you missed our live, online educational seminar, “Characterizing the maternal immune environment during pregnancy: Implications for autism spectrum disorders” we wanted to let you know that it is available in our complimentary on-demand archive.

You can access this archive to watch the webinar at any time.

For more information and access to the full archive of Science webinars, go to:

About This Webinar

Under normal conditions, the maternal immune system is uniquely regulated during pregnancy to maintain a pathogen-free, yet noninflammatory environment for the developing fetus. However, factors such as cytokines and chemokines produced during gestation can have developmental consequences for the fetus. In particular, maternal immune dysregulation during pregnancy has been frequently associated with increased risk of autism spectrum disorders. This webinar will discuss the relationship between the maternal immune environment and autism risk, highlighting findings from the largest population-based prospective study to date to have examined the relationship between mid-gestational maternal cytokines and chemokines and risk for autism.

During the webinar, the viewers will:

• Hear about recent research on the effects of in utero prenatal cytokine/chemokine levels
• Gain insight into how to successfully integrate multiplexed assays into your research
• Learn best practices for running multiplex protein detection assays to generate the best data
• Have the opportunity to get their questions answered live during the broadcast!


Karen Jones, Ph.D.
University of California, Davis
Davis, CA

Anthony J. Saporita, Ph.D.
St. Charles, MO

Register at:

Questions? E-mail:

Produced by the Science/AAAS Custom Publishing Office and sponsored by Merck KGaA, Darmstadt, Germany.